Administrative Contacts:
Infectious Diseases Office:
245 N 15th Street MS 461
New College Building 6314
tel: 215-762-6555
fax: 215-762-3031
HIV Office:
1427 Vine Street MS 959
tel: 215-762-8142
fax: 215-246-5841
What's New
We are pleased to announce that the Division of Infectious Diseases and HIV Medicine, in collaboration with University of Pennsylvania School of Medicine, Cheyney University, and Inovio Biomedical Corporation, will receive $2.8 million over four years from the Commonwealth Universal Research Enhancement (CURE) competitive grant program funded through Pennsylvania’s share of the 2009-2010 national tobacco settlement.
Funds will be used to conduct pre-clinical studies to test the safety and effect on the immune system of a DNA-based vaccine that is designed to treat persons who are chronically infected with the hepatitis C virus (HCV) and have not responded to currently available therapies. People with chronic HCV infection face an increased risk of developing hepatocellular cancer, a difficult-to-treat cancer with a poor prognosis. Researchers expect that developing a vaccine to better treat HCV will ultimately lead to a reduction in hepatocellular cancer.
To create a diverse applicant pool for high-level research positions, a research training program for students and faculty from Cheyney University will also be established through this grant.
Jeffrey M. Jacobson, M.D., chief of the Division of Infectious Diseases & HIV Medicine, is the principal investigator and Michele A. Kutzler, Ph.D., will serve as co-investigator for the grant. Working with Drs. Jacobson and Kutzler are Seth Welles, Ph.D., of Drexel University’s School of Public Health; Weiner of University of Pennsylvania School of Medicine; Sakkar Eva, Ph.D., and Abdel Bior, Ph.D., of Cheyney University; and Niranjan Sardesai, Ph.D., of Inovio Biomedical Corporation.
About Our Division
The prevention and control of infectious diseases is a critical component for protecting the health of any community. The global economy, international travel, and migration all contribute to the potential for infectious diseases to spread to new populations. In the United States, the Centers for Disease Control reports that 160,000 Americans die each year with an infectious disease as the underlying cause of death, and infectious illnesses account for 25 percent of all physician visits each year. In addition, there are currently an estimated one million individuals in the U.S. with HIV, with 40,000 more people being infected every year.
The Division of Infectious Diseases and HIV Medicine comprises several clinical and research programs which provide both treatment and prevention of infectious diseases, including HIV. Under the direction of Division Chief Jeffrey M. Jacobson, M.D., the division is expanding the translational research program, and investigating cutting-edge technologies and therapeutic treatments for the management and prevention of HIV and other infectious diseases. The infectious disease specialists in this division work closely with Drexel Medicine’s Department of Microbiology and Immunology in researching new treatments and vaccines for HIV and other infectious diseases. The division also collaborates with the School of Public Health on programs to educate our patients and the public about disease prevention and management.
Clinical Practice - Infectious Diseases
Infection control is one important part of our infectious disease work. Infection control refers to the policies, procedures, and activities which intend to prevent or reduce the risk of transmission of infectious diseases. Protecting patients in healthcare environments, such as hospitals, from contracting infections is an integral part of the work of Drexel University College of Medicine physicians, as more than 100,000 deaths in the U.S. each year are caused by healthcare-acquired infections.
Sexually transmitted infections (STIs) are a large component of infection prevention and control as well. According to CDC estimates, 19 million new STIs occur each year – half of them among young people ages 15 to 24. If untreated, STIs can lead to serious consequences in men and women, including infertility. In addition, individuals with STIs are at more likely to acquire HIV if they are exposed to the virus through sexual contact.
The division’s Travel Health Clinic, one of the region’s only official yellow fever vaccination sites, provides immunizations, antibiotics, and personalized health advice to travelers from the university and throughout the city.
The division’s infectious disease specialists provide daily consultations to Hahnemann University Hospital, a 636-bed acute care teaching hospital which is part of Tenet Health System. They also provide clinical consultations to other medical practices in the community. The division’s physicians serve as faculty for the program’s Infectious Disease Fellowship Program.
Clinical Practice - HIV Medicine
The division's HIV clinical site, the Partnership Comprehensive Care Practice (the Partnership), is the largest adult HIV care center in the region, serving more than 1,400 men and women. Founded in 1993, the Partnership's mission is "to enhance the quality of life for persons with HIV/AIDS by providing comprehensive, integrated HIV care to all individuals regardless of their ability to pay." The Partnership provides one-stop shopping for its patients, including primary and specialty HIV medical care, gynecological care, prenatal care, nutrition assessment, case management, pharmacy services, phlebotomy and laboratory services, psychiatric and behavioral health services, substance abuse treatment, HIV support groups, health educational programs, and rapid HIV testing.
The Partnership also has two satellite practices: one at St. Christopher's Hospital for Children (SCHC) and one at Kensington Hospital. Our HIV specialists are skilled at managing HIV throughout the life cycle, as well as patients’ co-morbidities, such as diabetes and hepatitis C. Experts in the Partnership's prenatal clinic work with HIV-infected women to prevent mother-to-child transmission, with a 0 percent transmission rate to date. The division's rapid HIV testing programs have screened more than 2,500 patients for HIV. |